LABFFOTCHealthcare · Drug Manufacturers - Specialty & Generic

Laboratorios Farmaceuticos Rovi, S.A.

$90.61+0.00%(+$0.00)

TickerSpark Score

64/100

Mixed

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LABFF research report →

52-Week Range50% of range

Low $90.61

Current $90.61

High $90.61

Companywww.rovi.es

Laboratorios Farmaceuticos Rovi, S. A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally.

CEO: Juan Lopez-Belmonte Encina
IPO: 2021
Employees: 2,197
HQ: Madrid, ES

Price Chart

+0.00% · this period

Valuation

Market Cap: $4.63B
P/E: 23.26
P/S: 4.14
P/B: 4.55
EV/EBITDA: 15.42
Div Yield: 1.56%

Profitability

Gross Margin: 63.23%
Op Margin: 22.81%
Net Margin: 17.79%
ROE: 20.89%
ROIC: 15.99%

Growth & Income

Revenue: $743.20M · -2.69%
Net Income: $140.39M · 2.56%
EPS: $2.75 · 3.00%
Op Income: $173.08M
FCF YoY: 57.93%

Performance & Tape

52W High: $90.61
52W Low: $90.61
50D MA: $90.61
200D MA: $90.61
Beta: 0.29
Avg Volume: 49.6

Get TickerSpark's AI analysis on LABFF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime